1. Moon DH, Maddahi J, Silverman DH, Glaspy JA, Phelps ME, Hoh CK (1998) Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med (USA) 39:431–435
2. Scheidhauer K, Scharl A, Pietrzyk U, Wagner R, Gohring UJ, Schomacker K, Schicha H (1996) Qualitative [18F]FDG positron emission tomography in primary breast cancer: Clinical relevance and practicability. Eur J Nucl Med (Germany) 23:618–623
3. Hoh CK, Schiepers C (1999) 18-FDG imaging in breast cancer. Semin Nucl Med (USA) 29:49–56
4. Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, Valk PE, Czernin J (2002) Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J Nucl Med (USA) 43:325–329
5. Avril N, Menzel M, Dose J, Schelling M, Weber W, Janicke F, Nathrath W, Schwaiger M (2001) Glucose metabolism of breast cancer assessed by 18F-FDG PET: Histologic and immunohistochemical tissue analysis. J Nucl Med (USA) 42:9–16